About us
Who we are
Myeloma Patients Europe (MPE) is a leading non-profit, European myeloma and AL amyloidosis patient advocacy organisation.
As an umbrella organisation representing 48 myeloma and AL amyloidosis patient groups across Europe, we collaborate with members to advocate for meaningful patient involvement throughout the drug development process, access to the best possible treatment, and improved outcomes and quality of life for patients.
MPE achieves this by generating evidence to understand patient needs, strengthening members with the support and information required to advocate effectively, and collaborating with important stakeholders on projects that benefit the patient community.